Product
Neomycin
Aliases
Neo-Fradin
5 clinical trials
12 indications
Indication
Impaired Vaccine ResponseIndication
Colorectal CancerIndication
Small Intestinal AdenocarcinomaIndication
Colorectal Cancer stage IV AJCC v8Indication
Small Intestinal Adenocarcinoma AJCC v8Indication
Stage IVA Colorectal Cancer AJCC v8Indication
Stage IVB Colorectal Cancer AJCC v8Indication
Stage IVC Colorectal Cancer AJCC v8Indication
Crohn's diseaseIndication
PrediabetesIndication
Anastomotic leakIndication
Microbial ColonizationClinical trial
A Human Experimental Medicine Study to Assess Whether the Gut Microbiota Regulates Specific and Non-specific Immune Responses to VaccinationStatus: Recruiting, Estimated PCD: 2027-10-01
Clinical trial
Pilot Trial of Fecal Microbiota Transplantation and Re-Introduction of Anti-PD-1 Therapy in dMMR Colorectal Adenocarcinoma Anti-PD-1 Non-RespondersStatus: Active (not recruiting), Estimated PCD: 2024-12-31
Clinical trial
Fundamental Modification of the Gut Microbiota in the Treatment of Refractory Crohn's DiseaseStatus: Completed, Estimated PCD: 2018-12-01
Clinical trial
Interventional Bioremediation of Microbiota in Metabolic SyndromeStatus: Terminated, Estimated PCD: 2018-01-01
Clinical trial
Analysis of Mechanism on the Efficacy of Oral Antibiotic Prophylaxis in Elective Colon and Rectal Surgery With Primary AnastomosisStatus: Recruiting, Estimated PCD: 2025-01-31